GENOR BIOPHARMA DL-00002 Net Asset Quality Index

GENOR BIOPHARMA DL-00002 net asset quality index. GENOR BIOPHARMA DL-00002 (67N0) has a Net Asset Quality Index of 82.9% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €1.32 Billion minus total liabilities of €226.09 Million yields net assets of €1.10 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of GENOR BIOPHARMA DL-00002 for net asset value and shareholders' equity analysis.